| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 5.40e-05 | 18 | 83 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.02e-04 | 4 | 83 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.53e-04 | 6 | 83 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.86e-04 | 31 | 83 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 3.45e-04 | 33 | 83 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 4.24e-04 | 431 | 83 | 8 | GO:0004984 | |
| GeneOntologyCellularComponent | lamellipodium membrane | 8.80e-05 | 22 | 83 | 3 | GO:0031258 | |
| GeneOntologyCellularComponent | muscle tendon junction | 2.31e-04 | 6 | 83 | 2 | GO:0005927 | |
| GeneOntologyCellularComponent | Flemming body | 3.92e-04 | 36 | 83 | 3 | GO:0090543 | |
| Domain | RIH_assoc | 1.56e-06 | 6 | 81 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 1.56e-06 | 6 | 81 | 3 | IPR013662 | |
| Domain | RIH_dom | 1.56e-06 | 6 | 81 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.56e-06 | 6 | 81 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.56e-06 | 6 | 81 | 3 | IPR015925 | |
| Domain | - | 1.56e-06 | 6 | 81 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.56e-06 | 6 | 81 | 3 | PF01365 | |
| Domain | Ins145_P3_rec | 1.56e-06 | 6 | 81 | 3 | PF08709 | |
| Domain | MIR | 9.23e-06 | 10 | 81 | 3 | PS50919 | |
| Domain | MIR | 9.23e-06 | 10 | 81 | 3 | PF02815 | |
| Domain | MIR | 9.23e-06 | 10 | 81 | 3 | SM00472 | |
| Domain | MIR_motif | 9.23e-06 | 10 | 81 | 3 | IPR016093 | |
| Domain | Ryanrecept_TM4-6 | 5.56e-05 | 3 | 81 | 2 | IPR009460 | |
| Domain | RyR | 5.56e-05 | 3 | 81 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 5.56e-05 | 3 | 81 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 5.56e-05 | 3 | 81 | 2 | PF06459 | |
| Domain | Ryan_recept | 5.56e-05 | 3 | 81 | 2 | IPR013333 | |
| Domain | Olfact_rcpt | 3.02e-04 | 393 | 81 | 8 | IPR000725 | |
| Domain | ARM-like | 1.13e-03 | 270 | 81 | 6 | IPR011989 | |
| Domain | CYTOCHROME_B5_2 | 1.40e-03 | 13 | 81 | 2 | PS50255 | |
| Domain | CYTOCHROME_B5_1 | 1.40e-03 | 13 | 81 | 2 | PS00191 | |
| Domain | Cyt-b5 | 1.63e-03 | 14 | 81 | 2 | PF00173 | |
| Domain | Cyt_B5-like_heme/steroid-bd | 1.63e-03 | 14 | 81 | 2 | IPR001199 | |
| Domain | Cyt-b5 | 1.63e-03 | 14 | 81 | 2 | SM01117 | |
| Domain | - | 1.63e-03 | 14 | 81 | 2 | 3.10.120.10 | |
| Domain | GPCR_Rhodpsn_7TM | 2.43e-03 | 670 | 81 | 9 | IPR017452 | |
| Domain | Sulfatase | 2.72e-03 | 18 | 81 | 2 | PF00884 | |
| Domain | Sulfatase_N | 2.72e-03 | 18 | 81 | 2 | IPR000917 | |
| Domain | - | 2.79e-03 | 222 | 81 | 5 | 1.25.10.10 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 2.82e-03 | 685 | 81 | 9 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 2.99e-03 | 691 | 81 | 9 | PS50262 | |
| Domain | GPCR_Rhodpsn | 3.02e-03 | 692 | 81 | 9 | IPR000276 | |
| Domain | PRAME_family | 3.03e-03 | 19 | 81 | 2 | IPR026271 | |
| Domain | ARM-type_fold | 3.54e-03 | 339 | 81 | 6 | IPR016024 | |
| Domain | zf-DHHC | 4.43e-03 | 23 | 81 | 2 | PF01529 | |
| Domain | DHHC | 5.22e-03 | 25 | 81 | 2 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 5.22e-03 | 25 | 81 | 2 | IPR001594 | |
| Domain | Alkaline_phosphatase_core | 7.96e-03 | 31 | 81 | 2 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 7.96e-03 | 31 | 81 | 2 | IPR017849 | |
| Domain | - | 7.96e-03 | 31 | 81 | 2 | 3.40.720.10 | |
| Domain | Serpin_CS | 8.47e-03 | 32 | 81 | 2 | IPR023795 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 35008942 | ||
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 2.70e-07 | 6 | 84 | 3 | 25966694 | |
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 2.70e-07 | 6 | 84 | 3 | 16844763 | |
| Pubmed | 4.72e-07 | 7 | 84 | 3 | 11860456 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 7.54e-07 | 8 | 84 | 3 | 19033399 | |
| Pubmed | DPP4 DOCK8 PTRH2 ATP11A ERMP1 PIGG HERC2 TUBGCP4 HEATR5B MED12 GAA SLC27A3 ITPR3 | 4.44e-06 | 1168 | 84 | 13 | 19946888 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22283974 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 20923324 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 38287534 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 20623540 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 8898078 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21699755 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 18586264 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 14550562 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 32809114 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 5.76e-06 | 2 | 84 | 2 | 21531043 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 16678258 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24285081 | ||
| Pubmed | Elevated plasma plasminogen activator inhibitor-1 in CD36 deficiency. | 5.76e-06 | 2 | 84 | 2 | 18820218 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 14985349 | ||
| Pubmed | Anticoagulant and antithrombotic properties of platelet protease nexin-1. | 5.76e-06 | 2 | 84 | 2 | 19855083 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 30532990 | ||
| Pubmed | Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. | 1.73e-05 | 3 | 84 | 2 | 9184208 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 19439404 | ||
| Pubmed | Cell surface flip-flop of phosphatidylserine is critical for PIEZO1-mediated myotube formation. | 1.73e-05 | 3 | 84 | 2 | 29799007 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 12208516 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 18403125 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 24155177 | ||
| Pubmed | PTRH2 gene mutation causes progressive congenital skeletal muscle pathology. | 1.73e-05 | 3 | 84 | 2 | 28175314 | |
| Pubmed | Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin. | 1.73e-05 | 3 | 84 | 2 | 29730765 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 29790226 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 7876312 | ||
| Pubmed | PAR-1 mediates the thrombin-induced mesothelial cell overproduction of VEGF and PAI-1. | 1.73e-05 | 3 | 84 | 2 | 23280079 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 21347312 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 17082641 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.73e-05 | 3 | 84 | 2 | 10788707 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 27315375 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.73e-05 | 3 | 84 | 2 | 7621815 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.73e-05 | 3 | 84 | 2 | 10473538 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 20819545 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 22516898 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.73e-05 | 3 | 84 | 2 | 9204703 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 22542663 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.73e-05 | 3 | 84 | 2 | 12213830 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 9242641 | ||
| Pubmed | RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle. | 1.73e-05 | 3 | 84 | 2 | 15024040 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 25239916 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 31625370 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 18643873 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 11159936 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.73e-05 | 3 | 84 | 2 | 4600883 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 7635066 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 1.91e-05 | 340 | 84 | 7 | 11875048 | |
| Pubmed | 1.91e-05 | 340 | 84 | 7 | 11802173 | ||
| Pubmed | 2.02e-05 | 343 | 84 | 7 | 32295537 | ||
| Pubmed | 2.13e-05 | 346 | 84 | 7 | 14611657 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 22100703 | ||
| Pubmed | A zonal organization of odorant receptor gene expression in the olfactory epithelium. | 3.45e-05 | 4 | 84 | 2 | 7683976 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 12811828 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 3.45e-05 | 4 | 84 | 2 | 23413940 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 19933990 | ||
| Pubmed | Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury. | 3.45e-05 | 4 | 84 | 2 | 22507835 | |
| Pubmed | Prothrombotic gene polymorphisms and atherothrombotic cerebral infarction. | 3.45e-05 | 4 | 84 | 2 | 12859287 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 17299841 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 9607712 | ||
| Pubmed | Tissue-specific cancer-related serpin gene cluster at human chromosome band 3q26. | 3.45e-05 | 4 | 84 | 2 | 10992299 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 23482488 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 18206662 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 9384575 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | SERPINE2 CYBRD1 DOLK SERPINE1 PTRH2 PAQR5 ERMP1 VPS16 FH DEGS1 XPOT | 4.92e-05 | 1061 | 84 | 11 | 33845483 |
| Pubmed | Fibrinolytic crosstalk with endothelial cells expands murine mesenchymal stromal cells. | 5.74e-05 | 5 | 84 | 2 | 27283026 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 16082623 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 23918386 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 5.74e-05 | 5 | 84 | 2 | 19011160 | |
| Pubmed | Macrophages of M1 phenotype have properties that influence lung cancer cell progression. | 5.74e-05 | 5 | 84 | 2 | 26050228 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 33060591 | ||
| Pubmed | Duplication and positive selection among hominin-specific PRAME genes. | 5.74e-05 | 5 | 84 | 2 | 16159394 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 18829111 | ||
| Pubmed | Early embryonic expression of murine coagulation system components. | 7.70e-05 | 34 | 84 | 3 | 11154109 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 8.59e-05 | 6 | 84 | 2 | 26025922 | |
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 8.59e-05 | 6 | 84 | 2 | 14592808 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 19009018 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 17934860 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 17182940 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 16352659 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDXDC1 RAB3GAP2 NUP88 PTRH2 ZDHHC17 HEATR5B GAA SLC27A3 XPOT ITPR3 | 9.15e-05 | 942 | 84 | 10 | 31073040 |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.08e-04 | 38 | 84 | 3 | 30786075 | |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 20962236 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 9949213 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 16356191 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 11784029 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 20302034 | ||
| Pubmed | Saturation mutagenesis defines novel mouse models of severe spine deformity. | 1.60e-04 | 8 | 84 | 2 | 34142127 | |
| Interaction | GPR17 interactions | 1.31e-06 | 283 | 77 | 9 | int:GPR17 | |
| Interaction | FPR2 interactions | 1.47e-05 | 138 | 77 | 6 | int:FPR2 | |
| Interaction | C3orf52 interactions | 2.14e-05 | 305 | 77 | 8 | int:C3orf52 | |
| Cytoband | 15q15 | 2.11e-04 | 12 | 83 | 2 | 15q15 | |
| Cytoband | 1q21 | 6.17e-04 | 91 | 83 | 3 | 1q21 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 3.03e-05 | 3 | 58 | 2 | 287 | |
| GeneFamily | Olfactory receptors, family 2 | 3.07e-05 | 113 | 58 | 5 | 149 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 2.67e-03 | 24 | 58 | 2 | 76 | |
| GeneFamily | PRAME family | 2.67e-03 | 24 | 58 | 2 | 686 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.89e-03 | 25 | 58 | 2 | 775 | |
| GeneFamily | Serpin peptidase inhibitors | 6.27e-03 | 37 | 58 | 2 | 739 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-06 | 192 | 84 | 6 | 44cb225392c8d07150955ecf203fbdf6021c9790 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 155 | 84 | 5 | 72a19a9ecfd13f6769c4b447d3ce01a855ec6ec7 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4|GI_large-bowel / Manually curated celltypes from each tissue | 1.16e-05 | 156 | 84 | 5 | 01f2c0c6a936dfb59bc727feef428a906ad2a80b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 161 | 84 | 5 | ed93cb6c133855a5c244821e1a260aae8ab4df9a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 161 | 84 | 5 | 0089d7bb305c592392791862a3341fc92af8f3e2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 187 | 84 | 5 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 187 | 84 | 5 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 187 | 84 | 5 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 187 | 84 | 5 | 976b74d081b7fba8620768613cc26f9262cd7b16 | |
| ToppCell | 11.5-Airway-Epithelial-Bud_tip_progenitor|Airway / Age, Tissue, Lineage and Cell class | 3.23e-05 | 193 | 84 | 5 | f0a07bb221a497a9f7cc706045d5205269be4515 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 195 | 84 | 5 | c54b19e31efe2c9ae690062569da7c0f1120a1d8 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.48e-05 | 196 | 84 | 5 | 88dc4e3efd7ea07617ecde142ec47cc57608f81b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | a6500d0d2e8bcac92381ab771dbdee66b0e1d48e | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.50e-06 | 7 | 81 | 3 | CID009547999 | |
| Drug | Br2BAPTA | 1.50e-06 | 7 | 81 | 3 | CID003081001 | |
| Drug | lercanidipine | 3.01e-06 | 63 | 81 | 5 | CID000065866 | |
| Drug | R 478 | 7.01e-06 | 11 | 81 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 7.01e-06 | 11 | 81 | 3 | CID003081323 | |
| Drug | 4-chloro-m-cresol | 8.98e-06 | 37 | 81 | 4 | CID000001732 | |
| Drug | Gvapspat amide | 1.91e-05 | 15 | 81 | 3 | CID000125015 | |
| Drug | etridiazole | 3.02e-05 | 50 | 81 | 4 | CID000017432 | |
| Drug | guanidinoacetate | 3.53e-05 | 52 | 81 | 4 | CID000000763 | |
| Drug | cis-diammineplatinum(II | 3.74e-05 | 3 | 81 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 3.74e-05 | 3 | 81 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 3.74e-05 | 3 | 81 | 2 | CID000127713 | |
| Drug | aminodantrolene | 3.74e-05 | 3 | 81 | 2 | CID009570289 | |
| Drug | AC1NE3ZL | 3.74e-05 | 3 | 81 | 2 | CID004636206 | |
| Drug | 2-hydroxycarbazole | 3.74e-05 | 3 | 81 | 2 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 3.74e-05 | 3 | 81 | 2 | CID005748312 | |
| Drug | AC1L1KRB | 4.11e-05 | 54 | 81 | 4 | CID000005621 | |
| Drug | Cinildipine | 4.74e-05 | 56 | 81 | 4 | CID000002752 | |
| Drug | creatine | 6.57e-05 | 193 | 81 | 6 | CID000000586 | |
| Drug | IAA-94 | 6.65e-05 | 61 | 81 | 4 | CID000003667 | |
| Drug | PCB74 | 7.47e-05 | 4 | 81 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 7.47e-05 | 4 | 81 | 2 | CID006444275 | |
| Drug | SC 38249 | 7.47e-05 | 4 | 81 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 7.47e-05 | 4 | 81 | 2 | CID000035682 | |
| Drug | arabinosyladenine | DPP4 PDE4C GUCY1B1 RBL2 SLC28A2 ATP11A MMP9 F2R RYR2 RYR3 ITPR3 | 7.89e-05 | 762 | 81 | 11 | CID000000191 |
| Drug | thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 8.00e-05 | 200 | 81 | 6 | 5921_DN | |
| Drug | T0702 | 9.43e-05 | 25 | 81 | 3 | CID000005908 | |
| Drug | gallopamil | 9.61e-05 | 67 | 81 | 4 | CID000001234 | |
| Disease | brain edema (biomarker_via_orthology) | 7.90e-06 | 15 | 78 | 3 | DOID:4724 (biomarker_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.07e-05 | 3 | 78 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.07e-05 | 3 | 78 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | familial hypercholesterolemia (is_marker_for) | 2.07e-05 | 3 | 78 | 2 | DOID:13810 (is_marker_for) | |
| Disease | familial encephalopathy with neuroserpin inclusion bodies (implicated_via_orthology) | 4.12e-05 | 4 | 78 | 2 | DOID:0050831 (implicated_via_orthology) | |
| Disease | Lead Poisoning | 1.44e-04 | 7 | 78 | 2 | C0023176 | |
| Disease | abdominal aortic aneurysm (implicated_via_orthology) | 2.45e-04 | 9 | 78 | 2 | DOID:7693 (implicated_via_orthology) | |
| Disease | interstitial lung disease (is_implicated_in) | 3.06e-04 | 10 | 78 | 2 | DOID:3082 (is_implicated_in) | |
| Disease | glomerulosclerosis (biomarker_via_orthology) | 3.06e-04 | 10 | 78 | 2 | DOID:0050851 (biomarker_via_orthology) | |
| Disease | glomerulosclerosis (implicated_via_orthology) | 3.74e-04 | 11 | 78 | 2 | DOID:0050851 (implicated_via_orthology) | |
| Disease | renal fibrosis (biomarker_via_orthology) | 4.48e-04 | 12 | 78 | 2 | DOID:0050855 (biomarker_via_orthology) | |
| Disease | focal segmental glomerulosclerosis (biomarker_via_orthology) | 4.48e-04 | 12 | 78 | 2 | DOID:1312 (biomarker_via_orthology) | |
| Disease | pre-eclampsia (is_marker_for) | 4.94e-04 | 58 | 78 | 3 | DOID:10591 (is_marker_for) | |
| Disease | thoracic aortic aneurysm (is_marker_for) | 6.15e-04 | 14 | 78 | 2 | DOID:14004 (is_marker_for) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 6.50e-04 | 148 | 78 | 4 | C0279702 | |
| Disease | relapsing-remitting multiple sclerosis (is_marker_for) | 7.08e-04 | 15 | 78 | 2 | DOID:2378 (is_marker_for) | |
| Disease | thrombosis (is_implicated_in) | 7.08e-04 | 15 | 78 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 9.14e-04 | 17 | 78 | 2 | OBA_2045173 | |
| Disease | Liver diseases | 9.29e-04 | 72 | 78 | 3 | C0023895 | |
| Disease | Liver Dysfunction | 9.29e-04 | 72 | 78 | 3 | C0086565 | |
| Disease | Prostatic Neoplasms | 1.23e-03 | 616 | 78 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.23e-03 | 616 | 78 | 7 | C0376358 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.26e-03 | 80 | 78 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | glaucoma (is_marker_for) | 1.27e-03 | 20 | 78 | 2 | DOID:1686 (is_marker_for) | |
| Disease | lung disease (is_marker_for) | 1.54e-03 | 22 | 78 | 2 | DOID:850 (is_marker_for) | |
| Disease | nevus count, cutaneous melanoma | 1.83e-03 | 91 | 78 | 3 | EFO_0000389, EFO_0004632 | |
| Disease | adult respiratory distress syndrome (is_marker_for) | 2.15e-03 | 26 | 78 | 2 | DOID:11394 (is_marker_for) | |
| Disease | macular degeneration (is_marker_for) | 2.15e-03 | 26 | 78 | 2 | DOID:4448 (is_marker_for) | |
| Disease | chronic obstructive pulmonary disease (biomarker_via_orthology) | 2.49e-03 | 28 | 78 | 2 | DOID:3083 (biomarker_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 2.57e-03 | 215 | 78 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | suntan | 2.60e-03 | 103 | 78 | 3 | EFO_0004279 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AALVAAHSAYLSPMA | 216 | Q5SZQ8 | |
| LRAFLMPIHVYSGIV | 151 | Q53TN4 | |
| LLVHSSRGPAHYEML | 11 | Q86Z23 | |
| TSGRPFLLYVALAHM | 236 | Q96EG1 | |
| LSMDGTLHTPAILLY | 206 | Q6P9G0 | |
| PEGMVTVAIAAHYLS | 856 | Q7Z2K6 | |
| HLTMHDYAPLVSGAL | 1061 | Q14573 | |
| MTLLASFLYSAHLPE | 226 | Q9NXK6 | |
| PMISDDLVNSYHLLL | 216 | Q08999 | |
| EMDLGAIPDLLHLAY | 986 | Q9H2M9 | |
| ALGLDHSSVPEALMY | 406 | P14780 | |
| SGPLILTHIYLLLGM | 401 | Q9UPQ8 | |
| HEYTMTLGLPEFIRA | 1246 | Q86VF7 | |
| HSSMEQDVGLLRLYP | 231 | Q86U10 | |
| LPLAVYHVSGEFAML | 271 | P13716 | |
| LLLGLHASYLAMSTP | 1311 | O95714 | |
| LIFLIYLDAGLHTPM | 46 | Q8NHB1 | |
| ILASLLDSQLHTPMY | 46 | Q9Y3N9 | |
| ILMLPLSLIATSYGH | 206 | Q8NG97 | |
| SLHEPLYIFLGMLGA | 56 | Q9UKL2 | |
| PADTLATYLLMLEGH | 366 | Q08493 | |
| YLLMGHSDVVNILSP | 311 | Q96LB9 | |
| MALLGHSLGAYISTL | 91 | Q6P996 | |
| LGSLMKTPDLEILHY | 66 | Q5VWM3 | |
| YNPISTIEGSMLHEL | 296 | Q96FE5 | |
| ITSFALGMSYHLPLV | 856 | Q93074 | |
| QITAPASMLIGDHYL | 286 | P27487 | |
| FIELPYHGESISMLI | 241 | P07093 | |
| YHGESISMLIALPTE | 246 | P07093 | |
| MIHELLLALSGYPGS | 1 | Q9UGJ1 | |
| LDALHDHLATIYPGM | 101 | Q02153 | |
| MLVLYGHSTQDLPET | 1 | Q9UNI1 | |
| GTTALYLFLLMHPSI | 606 | Q9H3R1 | |
| LTHLIGSPFLRAYMH | 386 | Q9BSC4 | |
| GLISLDSRLHAPMYF | 46 | Q96R45 | |
| HARPMYIFLGVLSVI | 56 | Q8NGC4 | |
| LHGPAMVKYLLLSIL | 6 | Q96PD4 | |
| YLMDAASLLPVLALG | 156 | Q96CB9 | |
| GLISLDSRLHAPMYF | 46 | O95047 | |
| PAVVYMLHLATADVL | 136 | P25116 | |
| ESPSHLYLAMELVTG | 81 | Q6P2M8 | |
| ELLYTDATVIPHLMA | 141 | Q8IUR7 | |
| LHSLALIVDSSGPMY | 956 | Q9P2D3 | |
| PSSLMLLNTAHEYLG | 886 | Q9Y6J0 | |
| LSMLEDHSYLPVGSV | 1676 | Q8NF50 | |
| VLIHLLMLESGYIPQ | 201 | Q9Y3I1 | |
| ESLMLVTALNPHIGY | 451 | P07954 | |
| YMLAASLLGLGLHPI | 211 | O15121 | |
| YITGLAEHLSPLMLS | 256 | P10253 | |
| QLLVMLPDSLHYSGV | 756 | Q13683 | |
| PLYISVGHRMSLEAA | 206 | Q8N8Q3 | |
| MPYLIGIHSSLIERV | 261 | Q6P3S1 | |
| FVYLADLLMPHLGAA | 91 | Q8N1S5 | |
| GYMEPTLRILAILHT | 4566 | Q92736 | |
| ILELPYHGDTLSMFI | 246 | P05121 | |
| PNILVIATESGMLYH | 321 | Q99567 | |
| HIPMYIFLSNLALTD | 56 | Q15612 | |
| VFPHRSLLYVMGVLS | 216 | Q6ZUA9 | |
| LLYHEPRSFEVGMLV | 401 | Q2TAK8 | |
| LVLHAYMDELSFLSP | 371 | Q5VWQ0 | |
| TLAHLLPAPAMYSLL | 66 | P41225 | |
| IFILPLMHTYAGLAV | 396 | Q7RTX9 | |
| LGSLMKTPDLEILHY | 66 | Q5SWL8 | |
| IGIIAYMLLTHTSPF | 221 | O94768 | |
| LLADELITVYSLPGM | 356 | Q9NR46 | |
| HLDIAPRYASILMGI | 426 | Q9P2U7 | |
| LGLLLGLHASYLAMS | 36 | Q9BVR0 | |
| IRPYLGDMTLSEIHA | 321 | O43868 | |
| LTMLESPLEGISHYH | 116 | Q8NF67 | |
| SLPILLYSLMEQHVG | 926 | P98196 | |
| LVMEYLAHPSTLGLA | 6 | Q9Y3E5 | |
| IVDMLTYLVSHVPLG | 101 | Q96B21 | |
| ALPLYHMSGSLLGIV | 326 | Q5K4L6 | |
| GYMAPTLRALAIIHT | 4471 | Q15413 | |
| MLVSTPLLHDALYLQ | 191 | P35916 | |
| LDIYSASGMPLASLL | 66 | Q9H269 | |
| YAAHDVTFIPLLMTL | 331 | Q9NPH0 | |
| DHSMHSALPLGIYLA | 351 | Q8IUH5 | |
| RLLYMLAEALPVSHG | 451 | O43592 | |
| PLHSLGHLIMDQSYV | 411 | Q92508 | |
| LLMHYPFIGDVHSLI | 391 | Q92609 | |
| GSLLLYLAVSLMDPG | 56 | Q96GR4 | |
| FSPKLLYEGMHLLIT | 951 | Q5H8A4 | |
| RMSEPLIAYILHEAL | 121 | Q8NEV4 | |
| DHYVLPGMTLSLAER | 271 | Q8N9F0 |